Nasdaq · CIK 0001752828
CELU Celularity Inc
Insider trading from SEC Form 4. Last filing 18 d ago.
Celularity Inc (CELU) has 45 SEC Form 4 filings on file from 10 insiders, the latest filed on Sep 25, 2026. No insider bought or sold on the open market in the last 90 days; rows filed in that time are grants, exercises, tax withholding and other transactions that carry no view on the price.
Last 90 days
Net insider value
$0
no open-market trades
Buys
0
$0 by 0 insiders
Sells
0
$0 by 0 insiders
Insiders on file
10
with a Form 4 at this company
Signals
Open-market buys and sells at Celularity Inc, scored.
No scored open-market trades yet. Grants, exercises and other rows are below.
Transactions
The newest 50 of 105 rows filed, every code.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 23, 2026 | Philip & Daniele Barach Family Trust owner | JOther Convertible Notesderivative | +192,771 | - | - | 2,000,000 | 18 d ago |
| Sep 23, 2026 | Daniele Wolf Barach owner | JOther Convertible Notesderivativeindirect: See Footnote | +192,771 | - | - | 2,000,000 | 18 d ago |
| Sep 23, 2026 | Philip Alan Barach director, owner | JOther Convertible Notesderivativeindirect: See Footnote | +192,771 | - | - | 2,000,000 | 18 d ago |
| Sep 23, 2026 | Daniele Wolf Barach owner | JOther Convertible Notesderivativeindirect: See Footnote | +2,140,000 | - | - | 2,140,000 | 18 d ago |
| Sep 23, 2026 | Philip & Daniele Barach Family Trust owner | JOther Convertible Notesderivative | +2,140,000 | - | - | 2,140,000 | 18 d ago |
| Sep 23, 2026 | Philip Alan Barach director, owner | JOther Convertible Notesderivativeindirect: See Footnote | +2,140,000 | - | - | 2,140,000 | 18 d ago |
| Sep 23, 2026 | Philip Alan Barach director, owner | JOther Warrantsderivativeindirect: See Footnote | +1,177,000 | - | - | 1,177,000 | 18 d ago |
| Sep 23, 2026 | Philip & Daniele Barach Family Trust owner | JOther Warrantsderivative | +1,177,000 | - | - | 1,177,000 | 18 d ago |
| Sep 23, 2026 | Daniele Wolf Barach owner | JOther Warrantsderivativeindirect: See Footnote | +1,177,000 | - | - | 1,177,000 | 18 d ago |
| Sep 23, 2026 | Philip Alan Barach director, owner | JOther Convertible Notesderivativeindirect: See Footnote | +1,457,765 | - | - | 1,457,765 | 18 d ago |
| Sep 23, 2026 | Philip & Daniele Barach Family Trust owner | JOther Convertible Notesderivative | +1,457,765 | - | - | 1,457,765 | 18 d ago |
| Sep 23, 2026 | Daniele Wolf Barach owner | JOther Convertible Notesderivativeindirect: See Footnote | +1,457,765 | - | - | 1,457,765 | 18 d ago |
| Sep 23, 2026 | Philip Alan Barach director, owner | JOther Warrantsderivativeindirect: See Footnote | +1,457,765 | - | - | 1,457,765 | 18 d ago |
| Sep 23, 2026 | Daniele Wolf Barach owner | JOther Warrantsderivativeindirect: See Footnote | +1,457,765 | - | - | 1,457,765 | 18 d ago |
| Sep 23, 2026 | Philip & Daniele Barach Family Trust owner | JOther Warrantsderivative | +1,457,765 | - | - | 1,457,765 | 18 d ago |
| Jun 19, 2026 | Daniele Wolf Barach owner | JOther Convertible Notesderivativeindirect: See Footnote | -1,204,819 | - | - | 0 | Jun 23, 2026 |
| Jun 19, 2026 | Philip Alan Barach owner | JOther Convertible Notesderivativeindirect: See Footnote | -1,204,819 | - | - | 0 | Jun 23, 2026 |
| Jun 19, 2026 | Philip & Daniele Barach Family Trust owner | JOther Convertible Notesderivative | -1,204,819 | - | - | 0 | Jun 23, 2026 |
| Jun 19, 2026 | Daniele Wolf Barach owner | JOther Warrantsderivativeindirect: See Footnote | -839,160 | - | - | 0 | Jun 23, 2026 |
| Jun 19, 2026 | Philip Alan Barach owner | JOther Warrantsderivativeindirect: See Footnote | -839,160 | - | - | 0 | Jun 23, 2026 |
| Jun 19, 2026 | Philip & Daniele Barach Family Trust owner | JOther Warrantsderivative | -839,160 | - | - | 0 | Jun 23, 2026 |
| Apr 13, 2026 | Stephen Brigido Pres., Functional Regeneration | MOption exercise Class A Common Stock | +821 | $0.00 | $0 | 9,742 | Apr 15, 2026 |
| Apr 13, 2026 | Robert J Hariri Chief Executive Officer | MOption exercise Class A Common Stock | +3,281 | $0.00 | $0 | 2,854,735 | Apr 15, 2026 |
| Apr 13, 2026 | John R Haines Senior Exec Vice President | MOption exercise Class A Common Stock | +1,641 | $0.00 | $0 | 30,762 | Apr 15, 2026 |
| Apr 13, 2026 | Stephen Brigido Pres., Functional Regeneration | FTax withholding Class A Common Stock | -268 | $1.28 | $343 | 9,474 | Apr 15, 2026 |
| Apr 13, 2026 | Robert J Hariri Chief Executive Officer | FTax withholding Class A Common Stock | -1,182 | $1.28 | $1,513 | 2,853,553 | Apr 15, 2026 |
| Apr 13, 2026 | John R Haines Senior Exec Vice President | FTax withholding Class A Common Stock | -583 | $1.28 | $746 | 30,179 | Apr 15, 2026 |
| Apr 13, 2026 | Stephen Brigido Pres., Functional Regeneration | MOption exercise Restricted Stock Unitsderivative | -821 | $0.00 | $0 | 0 | Apr 15, 2026 |
| Apr 13, 2026 | Robert J Hariri Chief Executive Officer | MOption exercise Restricted Stock Unitsderivative | -3,281 | $0.00 | $0 | 0 | Apr 15, 2026 |
| Apr 13, 2026 | John R Haines Senior Exec Vice President | MOption exercise Restricted Stock Unitsderivative | -1,641 | $0.00 | $0 | 0 | Apr 15, 2026 |
| Jan 12, 2026 | Vincent LeVien director | AGrant or award Class A Common Stock | +28,847 | $0.00 | $0 | 153,847 | Jan 15, 2026 |
| Jan 12, 2026 | Geoffrey Ling M.D. director | AGrant or award Class A Common Stock | +19,231 | $0.00 | $0 | 256,026 | Jan 15, 2026 |
| Jan 12, 2026 | Peter Diamandis director | AGrant or award Class A Common Stock | +20,385 | $0.00 | $0 | 394,150 | Jan 15, 2026 |
| Jan 12, 2026 | Diane L. Parks director | AGrant or award Class A Common Stock | +30,000 | $0.00 | $0 | 520,021 | Jan 15, 2026 |
| Jan 12, 2026 | Peter Diamandis director | AGrant or award Class A Common Stock | +20,385 | $0.00 | $0 | 394,150 | Jan 14, 2026 |
| Jan 12, 2026 | Vincent LeVien director | AGrant or award Class A Common Stock | +28,847 | $0.00 | $0 | 153,847 | Jan 14, 2026 |
| Jan 12, 2026 | Geoffrey Ling M.D. director | AGrant or award Class A Common Stock | +19,231 | $0.00 | $0 | 256,026 | Jan 14, 2026 |
| Jan 12, 2026 | Diane L. Parks director | AGrant or award Class A Common Stock | +30,000 | $0.00 | $0 | 520,021 | Jan 14, 2026 |
| Dec 29, 2025 | Peter Diamandis director | AGrant or award Class A Common Stock | +125,000 | $0.00 | $0 | 373,765 | Dec 30, 2025 |
| Dec 29, 2025 | Diane L. Parks director | AGrant or award Class A Common Stock | +125,000 | $0.00 | $0 | 490,021 | Dec 30, 2025 |
| Dec 29, 2025 | Geoffrey Ling M.D. director | AGrant or award Class A Common Stock | +125,000 | $0.00 | $0 | 236,795 | Dec 30, 2025 |
| Dec 29, 2025 | Vincent LeVien director | AGrant or award Class A Common Stock | +125,000 | $0.00 | $0 | 125,000 | Dec 30, 2025 |
| Dec 29, 2025 | Peter Diamandis director | AGrant or award Stock Optionsderivative | +156,250 | $0.00 | $0 | 518,774 | Dec 30, 2025 |
| Dec 29, 2025 | Diane L. Parks director | AGrant or award Stock Optionsderivative | +156,250 | $0.00 | $0 | 518,774 | Dec 30, 2025 |
| Dec 29, 2025 | Geoffrey Ling M.D. director | AGrant or award Stock Optionsderivative | +156,250 | $0.00 | $0 | 1,490,996 | Dec 30, 2025 |
| Dec 29, 2025 | Vincent LeVien director | AGrant or award Stock Optionsderivative | +156,250 | $0.00 | $0 | 156,250 | Dec 30, 2025 |
| Dec 19, 2025 | Peter Diamandis director | AGrant or award Class A Common Stock | +67,416 | $0.00 | $0 | 248,765 | Dec 22, 2025 |
| Dec 19, 2025 | Geoffrey Ling M.D. director | AGrant or award Class A Common Stock | +67,416 | $0.00 | $0 | 111,795 | Dec 22, 2025 |
| Dec 19, 2025 | Diane L. Parks director | AGrant or award Class A Common Stock | +67,416 | $0.00 | $0 | 365,021 | Dec 22, 2025 |
| Nov 19, 2025 | Peter Diamandis director | AGrant or award Class A Common Stock | +47,042 | $0.00 | $0 | 248,765 | Nov 21, 2025 |
50 of 105 rows shown.
Insiders
Everyone who has filed a Form 4 here.
- Daniele Wolf Barachowner
- Philip Alan Barachdirector, owner
- Stephen BrigidoPres., Functional Regeneration
- Peter Diamandisdirector
- John R HainesSenior Exec Vice President
- Robert J HaririChief Executive Officer
- Vincent LeViendirector
- Geoffrey Ling M.D.director
- Diane L. Parksdirector
- Philip & Daniele Barach Family Trustowner
Questions about CELU
Answered from the filings on this page, as of the latest one.
Are insiders buying CELU?
No. In the last 90 days no insider at Celularity Inc bought or sold shares on the open market according to SEC Form 4 filings. The rows on file from that period are grants, exercises, tax withholding or other transactions, which carry no view on the price.
Who was the last insider to trade CELU on the open market?
No open-market trade has been scored at Celularity Inc. The latest Form 4 on file was filed on Sep 25, 2026 and holds grants, exercises or other rows that are not market trades.
How many insiders file Form 4 at Celularity Inc?
10 people have filed a Form 4 at Celularity Inc, among them Daniele Wolf Barach (10% owner), Philip Alan Barach (director and 10% owner), Stephen Brigido (Pres., Functional Regeneration). Officers, directors and holders of more than 10% of a share class must report their trades within two business days.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.